Elevated Capital Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-37,097
| Closed | -$1.32M | – | 173 |
|
|
2023
Q2 | $1.32M | Buy |
37,097
+635
| +2% | +$22.6K | 0.44% | 82 |
|
|
2023
Q1 | $1.3M | Sell |
36,462
-295
| -0.8% | -$10.5K | 0.46% | 80 |
|
|
2022
Q4 | $1.29M | Buy |
36,757
+2,252
| +7% | +$79.1K | 0.49% | 72 |
|
|
2022
Q3 | $1.02M | Buy |
+34,505
| New | +$1.02M | 0.4% | 89 |
|
|
2022
Q1 | $1.02M | Buy |
+18,638
| New | +$1.02M | 0.34% | 99 |
|
|
2021
Q3 | $765K | Buy |
+16,014
| New | +$765K | 0.26% | 111 |
|
|
2021
Q1 | $634K | Buy |
13,459
+697
| +5% | +$32.8K | 0.25% | 116 |
|
|
2020
Q4 | $587K | Sell |
12,762
-780
| -6% | -$35.9K | 0.25% | 115 |
|
|
2020
Q3 | $657K | Sell |
13,542
-504
| -4% | -$24.5K | 0.31% | 107 |
|
|
2020
Q2 | $701K | Buy |
+14,046
| New | +$701K | 0.33% | 107 |
|
|
2019
Q4 | $419K | Buy |
+7,133
| New | +$419K | 0.47% | 62 |
|
|
2019
Q1 | $824K | Buy |
+16,552
| New | +$824K | 0.54% | 60 |
|